Enhanced CAR-T therapy clears solid tumours by finding ‘faint’ targets
In CAR T-cell therapy, a patient’s T cells (one shown) are isolated, engineered to target specific cancer cells, then reinfused to mount their attack. | Photo Credit: NIAID/Unsplash Chimeric antigen receptor (CAR) T-cell therapy, an approach that modifies a patient’s own immune cells to hunt down cancer, has transformed treatment for blood cancers such as…
Read More “Enhanced CAR-T therapy clears solid tumours by finding ‘faint’ targets” »
